





 | |
January, 30, 2001
In general, the project is
progressing smoothly. Our top
priority is to enter into an agreement with the best possible company to
distribute Oralbot. Distribution is
the most important element of any business.
We want to be linked to a distributor that will provide the greatest
sales volume and, consequently, provide excellent returns to our royalty
participants. For this reason, we
want to take sufficient time to make the right decision.
We are talking to a number of candidate companies.
Selection of the right distributor is vital. We want a company with an excellent reputation, healthy
financial position and strong name recognition within the industry.
We recently attended the Denver Mid-winter Dental Convention where we
made contact with several leading companies that are now Oralbot distributor
prospects. We are fortunate to be
in a position of making our selection from a large list of well-qualified
distributors. Our goal is to
finalize a world-exclusive distribution agreement by March 31, 2001.
We have purposely delayed conducting the clinical
test until we have finalized an agreement with a distributor because those we
have been talking to indicate that they want to participate in developing the
test protocol. They want a test result that will best fit their marketing strategy.
|